newsfilter
← Latest News
GlobeNewswire·

Brain Cancer Breakthrough Hopes, a $30 Million Robotics Deal and an AI Gold Rush

  • NeOnc Technologies (NASDAQ:NTHI) secured a Type B End-of-Phase FDA meeting for early January 2027 to discuss accelerated approval for its intranasal brain cancer treatment NEO100, following Phase 2a results showing a 48.9% six-month progression-free survival rate.
  • NeOnc CEO Amir Heshmatpour purchased approximately $1.11 million of company stock in 2026, while short interest rose to over 920,000 shares by late October.
  • INLIF Limited (NASDAQ:INLF) established a three-year, $30 million supply framework with Jinjiang Hengsheng Toys via its subsidiary Ewatt Robot Equipment, targeting $5 million in procurement every six months.
  • CoreWeave (NASDAQ:CRWV) launched CoreWeave Database, a managed PostgreSQL service integrated with its Kubernetes clusters, to reduce latency for AI workloads.
  • CoreWeave reported Q3 revenue of $3.66 billion, a 168% year-over-year increase, and a $132.5 billion backlog, while raising its 2026 revenue outlook to $13.0-$13.3 billion.
  • CoreWeave incurred a $709 million quarterly net loss and $846 million in net interest expense, offset by raising $4.2 billion through convertible notes and establishing an equity program for up to 35 million shares.
  • Ohmyswift (NASDAQ:OMH), formerly Ohmyhome, completed its legal name change from the Cayman Islands to the British Virgin Islands on November 3, 2026, after shareholder approval.
  • Ohmyswift executed a 1-for-50 reverse share consolidation on August 31, reducing its Class A share count from approximately 95.6 million to 1.91 million shares.
  • Ohmyswift is seeking a new CUSIP to reflect its corporate restructuring, despite its Class A shares continuing to trade under the OMH ticker.
Company
24/7 Market News
Keywords
24/7 Market News, $NHTI, $INLF, $CRWV, Investment Opinion